Playa Vista, CA, United States of America

Michel C Maillard

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 12.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2017 - 2018)
  • Playa Vista, CA (US) (2018)
  • Playa Visa, CA (US) (2018)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Michel C Maillard: Innovator in Medical Research

Introduction

Michel C Maillard is a prominent inventor based in Playa Vista, CA (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 6 patents to his name, Maillard's work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents, Maillard has developed Rho kinase inhibitors and compositions and methods of use thereof. These inhibitors are particularly useful as medicaments for the treatment of Huntington's disease. Additionally, he has worked on histone deacetylase inhibitors and compositions and methods of use thereof, which include certain HDAC inhibitors of Formula I, along with their compositions and methods of application.

Career Highlights

Michel C Maillard is currently associated with the CHDI Foundation, Inc., where he continues to advance his research and innovation in the medical field. His work focuses on creating effective treatments that can significantly improve patient outcomes.

Collaborations

Maillard collaborates with notable colleagues, including Celia Dominguez and Christopher A Luckhurst, who contribute to his research endeavors and help drive innovation in their projects.

Conclusion

Michel C Maillard's contributions to medical research through his patents and collaborations highlight his commitment to advancing healthcare solutions. His innovative work continues to pave the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…